Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

This publication has 10 references indexed in Scilit:

• Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
  Cancer Cell, 2014
• Polo-like kinases: structural variations lead to multiple functions
  Nature Reviews Molecular Cell Biology, 2014
• Functional Viability Profiles of Breast Cancer
  Cancer Discovery, 2011
• Plk4 trans-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation
  Journal of Cell Science, 2010
• Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability
  Journal of Cell Biology, 2010
• Centrioles, Centrosomes, and Cilia in Health and Disease
  Cell, 2009
• Mitotic drivers—inhibitors of the Aurora B Kinase
  Cancer and Metastasis Reviews, 2009
• Centrosome Amplification Can Initiate Tumorigenesis in Flies
  Cell, 2008
• The mighty mouse: genetically engineered mouse models in cancer drug development
  Nature Reviews Drug Discovery, 2006
• Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
  Nature Genetics, 2005